BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26976954)

  • 1. STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.
    Olson MR; Verdan FF; Hufford MM; Dent AL; Kaplan MH
    J Immunol; 2016 Apr; 196(8):3297-304. PubMed ID: 26976954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6 activates STAT5 in T cells.
    Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF
    Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production.
    Olson MR; Ulrich BJ; Hummel SA; Khan I; Meuris B; Cherukuri Y; Dent AL; Janga SC; Kaplan MH
    J Immunol; 2017 Jun; 198(11):4352-4359. PubMed ID: 28468971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression.
    Miller PG; Bonn MB; McKarns SC
    J Immunol; 2015 Sep; 195(6):2633-47. PubMed ID: 26268655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation.
    Canaria DA; Yan B; Clare MG; Zhang Z; Taylor GA; Boone DL; Kazemian M; Olson MR
    J Immunol; 2021 Sep; 207(5):1265-1274. PubMed ID: 34348976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal roles of STAT3 and STAT5 in nasal polyposis.
    Wang XQ; Hu GH; Kou W; Shen Y; Kang HY; Hong SL
    Am J Otolaryngol; 2012; 33(6):741-52. PubMed ID: 22959364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN drives Th17 cell differentiation by preventing IL-2 production.
    Kim HS; Jang SW; Lee W; Kim K; Sohn H; Hwang SS; Lee GR
    J Exp Med; 2017 Nov; 214(11):3381-3398. PubMed ID: 29018045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
    Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
    Front Immunol; 2018; 9():1755. PubMed ID: 30150979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncostatin M Suppresses Activation of IL-17/Th17 via SOCS3 Regulation in CD4+ T Cells.
    Son HJ; Lee SH; Lee SY; Kim EK; Yang EJ; Kim JK; Seo HB; Park SH; Cho ML
    J Immunol; 2017 Feb; 198(4):1484-1491. PubMed ID: 28093521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin I2-IP signalling regulates human Th17 and Treg cell differentiation.
    Liu W; Li H; Zhang X; Wen D; Yu F; Yang S; Jia X; Cong B; Ma C
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):335-44. PubMed ID: 24035274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced TCR-dependent activation through citrullination of a T-cell epitope enhances Th17 development by disruption of the STAT3/5 balance.
    Tibbitt C; Falconer J; Stoop J; van Eden W; Robinson JH; Hilkens CM
    Eur J Immunol; 2016 Jul; 46(7):1633-43. PubMed ID: 27173727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation.
    Yuan X; Dou Y; Wu X; Wei Z; Dai Y
    J Cell Mol Med; 2017 Sep; 21(9):2172-2183. PubMed ID: 28332288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells.
    Lee JH; Ulrich B; Cho J; Park J; Kim CH
    J Immunol; 2011 Aug; 187(4):1778-87. PubMed ID: 21768398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA.
    Masuda K; Ripley B; Nyati KK; Dubey PK; Zaman MM; Hanieh H; Higa M; Yamashita K; Standley DM; Mashima T; Katahira M; Okamoto T; Matsuura Y; Takeuchi O; Kishimoto T
    J Exp Med; 2016 Apr; 213(4):605-19. PubMed ID: 27022145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.
    Ju JH; Heo YJ; Cho ML; Jhun JY; Park JS; Lee SY; Oh HJ; Moon SJ; Kwok SK; Park KS; Park SH; Kim HY
    Arthritis Rheum; 2012 Nov; 64(11):3543-52. PubMed ID: 22736176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome.
    Zheng Y; Wang Z; Deng L; Zhang G; Yuan X; Huang L; Xu W; Shen L
    Clin Immunol; 2015 Mar; 157(1):65-77. PubMed ID: 25572535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5.
    Sen S; He Z; Ghosh S; Dery KJ; Yang L; Zhang J; Sun Z
    J Immunol; 2018 Jul; 201(2):440-450. PubMed ID: 29794014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of transcriptional factors stat5 and stat3 during human T-lymphocyte proliferation induced by different mitogenic stimuli].
    Karitskaia IA; Aksenov ND; Zenin VV; Khaĭdukova AL; Marakhova II
    Tsitologiia; 2006; 48(1):42-9. PubMed ID: 16568834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.